As one of the teams involved in the drug development for autoimmune diseases, Creative Biolabs leverages extensive first-hand experience to deliver industry-leading expertise and services for antibody analysis and characterization. We apply our scientific and regulatory expertise to support you at every stage of your drug development cycle, helping to accurately determine the function, immunogenic profile, safety, and efficacy of your therapeutic candidates.
Creative Biolabs is a leading custom service provider in drug development for autoimmune diseases. Based on our deep understanding of drug development and our advanced platforms, a series of antibody analysis services are available at:
Creative Biolabs provides comprehensive functional analysis services for complete functional evaluation of your antibody drugs for autoimmune diseases. We offer a variety of functional analysis services including but not limited to affinity measurement, cell proliferation assay, antibody-dependent cell-mediated cytotoxicity (ADCC) assay, complement-dependent cytotoxicity (CDC) assay, cytopathic effect inhibition (CPE), and reporter gene assay. Each project presents its own unique set of challenges, and our scientists will work closely with you to ensure that your drugs are properly developed and validated to meet all specific requirements.
Antibody drugs may induce an immune response in the body, leading to the development of anti-drug antibodies (ADAs). The neutralizing fraction of ADA not only decreases the therapeutic activity but also potentially threatens patient safety. Therefore, the assessment of immunogenicity is fundamental and crucial to biologic drug development. As an experienced partner, Creative Biolabs now offers a series of highly sensitive and precise immunogenicity testing to obtain rigorous immunogenicity data for preclinical and clinical drug development.
The inherent complexity of therapeutics like antibodies necessitates a comprehensive analysis program to ensure safety, efficacy, and quality. Creative Biolabs offers a full range of complement safety and efficacy validation services and uses high-quality standards, including the validation procedures and delivery reports. Our reliable safety and efficacy data will ensure you to make decisions on your programs and accelerate promising drug candidates through development to reach the clinic stage sooner.
With Creative Biolabs, you will work with an experienced partner who is knowledgeable in developing therapeutic antibodies for autoimmune diseases. Creative Biolabs supports a full range of services for antibody-based therapeutics, from functional analysis to safety and efficacy validation. If you are interested in our services, please do not hesitate to contact us for more details.
For Research Use Only | Not For Clinical Use